The connection between AAA and osteopontin was first described by Golledge et al,10 who found an association between osteopontin serum and tissue concentrations with human AAAs and suggested osteopontin as a useful biomarker for AAA presence and growth. The gene discussed is SPP1; the disease is achalasia-alacrima syndrome.